|
Univariate |
Univariate |
Univariate |
Multivariate |
Multivariate |
Multivariate |
|
OR |
95% CI |
p Value |
OR |
95% CI |
p Value |
Male sex |
2.31 |
1.28-4.15 |
0.005 |
1.05 |
0.43-2.56 |
0.91 |
Age |
1.01 |
0.99-1.04 |
0.31 |
|
|
|
Baseline QRS |
1.02 |
1.06-1.16 |
< 0.001 |
1.24 |
1.15-1.33 |
< 0.001 |
Atrial fibrillation |
2.32 |
0.95-5.70 |
0.065 |
0.63 |
0.12-2.14 |
0.46 |
Hypertension |
2.26 |
1.28-3.99 |
0.005 |
1.84 |
0.77-4.39 |
0.17 |
Heart Failure |
2.12 |
0.97-4.94 |
0.061 |
0.76 |
0.23-2.58 |
0.66 |
Ischemic cardiomyopathy |
1.96 |
0.58-6.64 |
0.29 |
|
|
|
LVEF |
0.98 |
0.95-1.00 |
0.048 |
1.00 |
0.98-1.01 |
0.77 |
LVEDV |
1.02 |
1.01-1.03 |
< 0.001 |
1.01 |
1.00-1.02 |
0.15 |
LVESV |
1.03 |
1.01-1.04 |
< 0.001 |
|
|
|
IVST |
1.12 |
0.98-1.27 |
0.088 |
1.20 |
1.02-1.40 |
0.025 |
PWT |
1.00 |
0.95-1.04 |
0.82 |
|
|
|
LAD |
1.14 |
1.08-1.20 |
< 0.001 |
1.08 |
1.01-1.16 |
0.024 |
E/e’ |
1.13 |
1.07-1.19 |
< 0.001 |
1.23 |
1.12-1.35 |
< 0.001 |
β blocker use |
2.12 |
1.19-3.80 |
0.011 |
0.70 |
0.30-1.65 |
0.42 |